Kouki Iida

Title: Kouki Iida: Innovator in Pharmaceutical Chemistry

Introduction

Kouki Iida is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address inflammatory responses. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Kouki Iida holds a patent for "Crystals of substituted cycloalkene derivatives." This invention aims to provide potassium salts of substituted cycloalkene derivatives that suppress the production of inflammatory mediators caused by intracellular signal transduction or cell activation induced by endotoxin. The patent includes specific compounds such as potassium (2-chloro-4-fluorophenyl){[(2R,3R,8R)-7-(ethoxycarbonyl)-2,3-bis(hydroxymethyl)-1,4-dioxaspiro[4.5]deca-6-en-8-yl]sulfonyl}azanide and potassium (2-bromo-4-fluorophenyl){[(2R,3R,8R)-7-(ethoxycarbonyl)-2,3-bis(hydroxymethyl)-1,4-dioxaspiro[4.5]deca-6-en-8-yl]sulfonyl}azanide. These compounds are designed to be used in pharmaceuticals for the treatment and prevention of sepsis.

Career Highlights

Kouki Iida is currently employed at Daiichi Sankyo Company, Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative pharmaceutical solutions that address critical health issues.

Collaborations

Kouki has collaborated with esteemed colleagues such as Nobuyuki Ohkawa and Takayoshi Nagasaki. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.

Conclusion

Kouki Iida's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his commitment to improving health outcomes. His work exemplifies the impact of dedicated research and collaboration in the field of medicine.